These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20809978)

  • 1. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
    St Guily JL; Borget I; Vainchtock A; Rémy V; Takizawa C
    Head Neck Oncol; 2010 Sep; 2():22. PubMed ID: 20809978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and economic burden of potentially HPV-related cancers in France.
    Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
    PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
    Rémy V; Mathevet P; Vainchtock A
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):210-4. PubMed ID: 19735968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
    Uhart M; Blein C; L'Azou M; Thomas L; Durand L
    Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
    Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
    PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
    Maravic M; Jouaneton B; Vainchtock A; Tochon V
    Clin Exp Rheumatol; 2012; 30(2):222-7. PubMed ID: 22546070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
    Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
    BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France.
    Scotte F; Martelli N; Vainchtock A; Borget I
    Adv Ther; 2015 Feb; 32(2):138-47. PubMed ID: 25716549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital burden of pulmonary arterial hypertension in France.
    Bergot E; De Leotoing L; Bendjenana H; Tournier C; Vainchtock A; Nachbaur G; Humbert M
    PLoS One; 2019; 14(9):e0221211. PubMed ID: 31536491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of HPV-related cancers in France.
    Borget I; Abramowitz L; Mathevet P
    Vaccine; 2011 Jul; 29(32):5245-9. PubMed ID: 21616117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inpatient costs of endophthalmitis evaluated for the whole of France.
    Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
    Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
    Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
    J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
    [No Abstract]   [Full Text] [Related]  

  • 14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of hospitalizations for head and neck neoplasm in Spain (1997-2008): an epidemiologic study.
    Gil-Prieto R; Viguera-Ester P; Álvaro-Meca A; San-Martín-Rodriguez M; Gil de Miguel Á
    Hum Vaccin Immunother; 2012 Jun; 8(6):788-98. PubMed ID: 22495113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
    Heng C; Rybarczyk-Vigouret MC; Michel B
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):144-51. PubMed ID: 25079654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
    Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
    Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.